Indication

Congenital heart defect requiring patency of ductus arteriosus

A congenital heart defect requiring patency of the ductus arteriosus—often termed a ductal-dependent congenital heart defect—refers to a critical cardiovascular malformation in neonates where post-birth survival relies on maintaining blood flow through the open fetal arterial channel. Read more about Congenital heart defect requiring patency of ductus arteriosus

6 drugs 6 manufacturers

Advertisement

Drugs that treat it

Common Congenital heart defect requiring patency of ductus arteriosus therapies.

Showing 1–6 of 6 drugs

ALPROSTADIL

CONGENITAL HEART DEFECT REQUIRING PATENCY OF DUCTUS ARTERIOSUS
SICOR PHARM.

ALPROSTADIL

CONGENITAL HEART DEFECT REQUIRING PATENCY OF DUCTUS ARTERIOSUS
Teva Parenteral Medicines

ALPROSTADIL

ALPROSTADIL·CONGENITAL HEART DEFECT REQUIRING PATENCY OF DUCTUS ARTERIOSUS
MEITHEAL PHARMA
Filter & compare in the drug finder →Opens the drug finder with Congenital heart defect requiring patency of ductus arteriosus preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Congenital heart defect requiring patency of ductus arteriosus.

A congenital heart defect requiring patency of the ductus arteriosus—often termed a ductal-dependent congenital heart defect—refers to a critical cardiovascular malformation in neonates where post-birth survival relies on maintaining blood flow through the open fetal arterial channel.

Affecting the cardiovascular system in the early neonatal period, these lesions encompass defects causing severe obstruction to systemic circulation, such as hypoplastic left heart syndrome or critical aortic coarctation; profound pulmonary blood flow restriction, such as pulmonary atresia or severe tetralogy of Fallot; or parallel circulation requiring mixing, such as transposition of the great arteries.

Without a patent ductus arteriosus to sustain pulmonary perfusion, systemic cardiac output, or vascular mixing, normal physiological ductal closure soon after birth leads to rapid clinical deterioration marked by profound hypoxemia, metabolic acidosis, cardiogenic shock, and circulatory collapse.

Personalize your experience

Follow Congenital heart defect requiring patency of ductus arteriosus and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it